PATENTS RELATED TO INFLUENZA (FLU)

Although Dr. Demchick also represents patent seekers with non-microbiological inventions, his doctorate is in microbiology. Microbiology has been the primary focus of his research and teaching. He especially loves dealing with patent searches and applications for involving microbiology.

Dr. Demchick is a scientist with a quarter of a century of research experience in academic, industrial and governmental settings.

If you are considering patent protection for an invention, Dr. Demchick will be glad to discuss the matter with you. There is no charge for an initial discussion.

The following sampling is to give you some sense of the types of influenza (flu) related inventions which have received United States patent protection. The patent list is not exhaustive and is certainly not a substitute for a proper patent search . It should be noted that only U.S. Patents are included.

It should be noted that spelling, form and typographical errors in the original patents are preserved here.

Cells for detection of influenza and parainfluenza viruses (United States Patent 7,150,965)

Chemiluminescent influenza diagnostic kit (United States Patent 7,081,352)

Cold-adapted equine influenza viruses (United States Patent 7,074,414)

Inactivated influenza virus vaccine for nasal or oral application (United States Patent 7,052,701)

Method for generating influenza viruses and vaccines (United States Patent 7,037,707)

Cold-adapted equine influenza viruses (United States Patent 7,029,903)

Influenza sensor (United States Patent 7,018,792)

Cells for detection of influenza and parainfluenza viruses (United States Patent 6,991,899)

Recombinant tryptophan mutants of influenza (United States Patent 6,974,686)

DNA transfection system for the generation of infectious influenza virus (United States Patent 6,951,754)

Influenza sensor (United States Patent 6,893,814)

Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents (United States Patent 6,884,414)

Inactivated influenza virus vaccine for nasal or oral application (United States Patent 6,861,244)

Immunogenic composition comprising an influenza virus with a temperature sensitive PB2 mutation (United States Patent 6,843,996)

Cold-adapted equine influenza viruses (United States Patent 6,824,784)

Method for the detection of influenza A/B viruses (United States Patent 6,811,971)

Recombinant influenza A viruses (United States Patent 6,800,288)

Proteosome influenza vaccine (United States Patent 6,743,900)

Peptide-based vaccine for influenza (United States Patent 6,740,325)

Throat lozenges for the treatment of Hemosphilus influenza (United States Patent 6,733,749)

Anti-human influenza virus antibody (United States Patent 6,720,409)

Cold-adapted equine influenza viruses (United States Patent 6,685,946)

Animal cells and processes for the replication of influenza viruses (United States Patent 6,656,720)

Cold-adapted equine influenza viruses (United States Patent 6,649,169)

Inactivated influenza virus vaccine for nasal or oral application (United States Patent 6,635,246)

Influenza sensor (United States Patent 6,627,396)

Cells for detection of influenza and parainfluenza viruses (United States Patent 6,610,474)

Influenza vaccine (United States Patent 6,605,457)

Cold-adapted equine influenza viruses (United States Patent 6,579,528)

Synthetic soil-extract materials and medicaments for influenza viruses based thereon (United States Patent 6,576,229)

Dimeric inhibitors of influenza neuraminidase (United States Patent 6,548,476)

Therapy of respiratory influenza virus infection using free and liposome-encapsulated ribonucleotides (United States Patent 6,544,958)

Influenza vaccine composition with chitosan adjuvant (United States Patent 6,534,065)

Recombinant trytophan mutants of influenza (United States Patent 6,528,064)

Cyclopentane and cyclopentene compounds and use for detecting influenza virus (United States Patent 6,503,745)

Pharmaceutical composition for treating or preventing influenza, and novel capped oligonucleotide (United States Patent 6,495,675)

Cold-adapted equine influenza viruses (United States Patent 6,482,414)

Safe botanical drug for treatment and prevention of influenza and increasing immune function (United States Patent 6,475,531)

Animal cells and processes for the replication of influenza viruses (United States Patent 6,455,298)

Composition for treating symptoms of influenza (United States Patent 6,455,070)

Cold -adapted equine influenza viruses (United States Patent 6,436,408)

Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery (United States Patent 6,416,997)

Influenza virus vaccine composition (United States Patent 6,372,223)

Method of allophycocyanin inhibition of enterovirus and influenza virus reproduction resulting in cytopathic effect (United States Patent 6,346,408)

Influenza virus replicated in mammalian cell culture and vaccine production (United States Patent 6,344,354)

Polypeptides for use in generating anti-human influenza virus antibodies (United States Patent 6,337,070)

Recombinant tryptophan mutants of influenza (United States Patent 6,322,967)

Vaccine against swine influenza virus (United States Patent 6,287,570)

Compounds, compositions and methods for treating influenza (United States Patent 6,271,373)

Method and reagent for inhibiting influenza virus replication (United States Patent 6,258,585)

Method for producing influenza hemagglutinin multivalent vaccines (United States Patent 6,245,532)

Method of detection of influenza virus and compounds for use therein (United States Patent 6,242,582)

Compounds, compositions and methods for treating influenza (United States Patent 6,180,628)

Cold-adapted equine influenza viruses (United States Patent 6,177,082)

Preparation and use of recombinant influenza A virus M2 construct vaccines (United States Patent 6,169,175)

Influenza vaccine compositions (United States Patent 6,136,606)

Compounds and their combinations for the treatment of influenza infection (United States Patent 6,107,281)

Crystallized N-terminal domain of influenza virus matrix protein M1 and method of determining and using same (United States Patent 6,090,609)

Recombinant tryptophan mutants of influenza (United States Patent 6,090,391)

Methods for inhibition of membrane fusion-associated events, including influenza virus (United States Patent 6,068,973)

Pharmaceutical suppository composites for fever and influenza and method of producing the composites (United States Patent 6,063,383)

Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission (United States Patent 6,060,065)

Method for preparing an influenza virus, antigens obtained and applications thereof (United States Patent 6,048,537)

Vaccines for equine influenza (United States Patent 6,045,790)

Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B (United States Patent 6,015,664)

Compounds and their combinations for the treatment of influenza infection (United States Patent 6,013,632)

Method and apparatus for detecting cancer, influenza, or HIV based on .alpha.-N-acetyl-galactosaminidase detection (United States Patent 5,998,132)

Influenza vaccine (United States Patent 5,962,298)

Influenza vaccine (United States Patent 5,948,410)

Compounds, compositions and methods for treating influenza (United States Patent 5,935,957)

Liposomal influenza vaccine composition and method (United States Patent 5,919,480)

DNA transcription unit vaccines that protect against avian influenza viruses and methods of use thereof (United States Patent 5,916,879)

Cross-reactive influenza A immunization (United States Patent 5,882,650)

Genetically engineered human immunodeficiency virus-like particles with modified chimeric envelope glycoproteins containing influenza virus transmembrane spanning domains (United States Patent 5,879,925)

Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them (United States Patent 5,879,685)

Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein (United States Patent 5,858,368)

Capped nucleic acid oligomers that inhibit cap-dependent transcription of the influenza virus endonuclease (United States Patent 5,837,852)

Method of treating of preventing influenza (United States Patent 5,824,641)

Influenza virus replicated in mammalian cell culture and vaccine production (United States Patent 5,824,536)

Compounds compositions and methods for treating influenza (United States Patent 5,821,243)

Diagnostic and prognostic ELISA assays of serum .alpha.-N-acetylgalactosaminidase for influenza (United States Patent 5,776,671)

Cross-reactive influenza a immunization (United States Patent 5,766,601)

Method for producing influenza hemagglutinin multivalent vaccines using baculovirus (United States Patent 5,762,939)

Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive (United States Patent 5,741,493)

4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens (United States Patent 5,719,020)

Method for producing influenza virus and vaccine (United States Patent 5,698,433)

Saccharomyces cerevisiae expressing M.sub.2 protein of influenza A virus (United States Patent 5,691,189)

Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene (United States Patent 5,690,937)

DNA coding for variable region to human influenza A type virus (United States Patent 5,684,146)

Pyrazole dimers compositions and methods for treating influenza (United States Patent 5,684,024)

Cross-reactive influenza a immunization (United States Patent 5,674,502)

Methods for diagnosing human influenza and 4-position modified chromogenic N-acetylneuraminic acid substrated for use therein (United States Patent 5,663,055)

DNA polymerase extension assay for influenza virus endonuclease (United States Patent 5,660,989)

Influenza machine (United States Patent 5,639,461)

Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions (United States Patent 5,637,573)

Anti-human influenza virus antibody (United States Patent 5,631,350)

Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease (United States Patent 5,618,830)

M-protein peptides of influenza virus as antiviral agents (United States Patent 5,616,327)

Influenza virus subunit conjugates (United States Patent 5,612,037)

Anti-human influenza virus antibody (United States Patent 5,589,174)

Cells for detection of influenza and parainfluenza viruses (United States Patent 7,150,965)

Chemiluminescent influenza diagnostic kit (United States Patent 7,081,352)

Cold-adapted equine influenza viruses (United States Patent 7,074,414)

Inactivated influenza virus vaccine for nasal or oral application (United States Patent 7,052,701)

Method for generating influenza viruses and vaccines (United States Patent 7,037,707)

Cold-adapted equine influenza viruses (United States Patent 7,029,903)

Influenza sensor (United States Patent 7,018,792)

Cells for detection of influenza and parainfluenza viruses (United States Patent 6,991,899)

Recombinant tryptophan mutants of influenza (United States Patent 6,974,686)

DNA transfection system for the generation of infectious influenza virus (United States Patent 6,951,754)

Influenza sensor (United States Patent 6,893,814)

Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents (United States Patent 6,884,414)

Inactivated influenza virus vaccine for nasal or oral application (United States Patent 6,861,244)

Immunogenic composition comprising an influenza virus with a temperature sensitive PB2 mutation (United States Patent 6,843,996)

Cold-adapted equine influenza viruses (United States Patent 6,824,784)

Method for the detection of influenza A/B viruses (United States Patent 6,811,971)

Recombinant influenza A viruses (United States Patent 6,800,288)

Proteosome influenza vaccine (United States Patent 6,743,900)

Peptide-based vaccine for influenza (United States Patent 6,740,325)

Throat lozenges for the treatment of Hemosphilus influenza (United States Patent 6,733,749)

Anti-human influenza virus antibody (United States Patent 6,720,409)

Cold-adapted equine influenza viruses (United States Patent 6,685,946)

Animal cells and processes for the replication of influenza viruses (United States Patent 6,656,720)

Cold-adapted equine influenza viruses (United States Patent 6,649,169)

Inactivated influenza virus vaccine for nasal or oral application (United States Patent 6,635,246)

Influenza sensor (United States Patent 6,627,396)

Cells for detection of influenza and parainfluenza viruses (United States Patent 6,610,474)

Influenza vaccine (United States Patent 6,605,457)

Cold-adapted equine influenza viruses (United States Patent 6,579,528)

Synthetic soil-extract materials and medicaments for influenza viruses based thereon (United States Patent 6,576,229)

Dimeric inhibitors of influenza neuraminidase (United States Patent 6,548,476)

Therapy of respiratory influenza virus infection using free and liposome-encapsulated ribonucleotides (United States Patent 6,544,958)

Influenza vaccine composition with chitosan adjuvant (United States Patent 6,534,065)

Recombinant trytophan mutants of influenza (United States Patent 6,528,064)

Cyclopentane and cyclopentene compounds and use for detecting influenza virus (United States Patent 6,503,745)

Pharmaceutical composition for treating or preventing influenza, and novel capped oligonucleotide (United States Patent 6,495,675)

Cold-adapted equine influenza viruses (United States Patent 6,482,414)

Safe botanical drug for treatment and prevention of influenza and increasing immune function (United States Patent 6,475,531)

Animal cells and processes for the replication of influenza viruses (United States Patent 6,455,298)

Composition for treating symptoms of influenza (United States Patent 6,455,070)

Cold -adapted equine influenza viruses (United States Patent 6,436,408)

Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery (United States Patent 6,416,997)

Influenza virus vaccine composition (United States Patent 6,372,223)

Method of allophycocyanin inhibition of enterovirus and influenza virus reproduction resulting in cytopathic effect (United States Patent 6,346,408)

Influenza virus replicated in mammalian cell culture and vaccine production (United States Patent 6,344,354)

Polypeptides for use in generating anti-human influenza virus antibodies (United States Patent 6,337,070)

Recombinant tryptophan mutants of influenza (United States Patent 6,322,967)

Vaccine against swine influenza virus (United States Patent 6,287,570)

Compounds, compositions and methods for treating influenza (United States Patent 6,271,373)

Method and reagent for inhibiting influenza virus replication (United States Patent 6,258,585)

Method for producing influenza hemagglutinin multivalent vaccines (United States Patent 6,245,532)

Method of detection of influenza virus and compounds for use therein (United States Patent 6,242,582)

Compounds, compositions and methods for treating influenza (United States Patent 6,180,628)

Cold-adapted equine influenza viruses (United States Patent 6,177,082)

Preparation and use of recombinant influenza A virus M2 construct vaccines (United States Patent 6,169,175)

Influenza vaccine compositions (United States Patent 6,136,606)

Compounds and their combinations for the treatment of influenza infection (United States Patent 6,107,281)

Crystallized N-terminal domain of influenza virus matrix protein M1 and method of determining and using same (United States Patent 6,090,609)

Recombinant tryptophan mutants of influenza (United States Patent 6,090,391)

Methods for inhibition of membrane fusion-associated events, including influenza virus (United States Patent 6,068,973)

Pharmaceutical suppository composites for fever and influenza and method of producing the composites (United States Patent 6,063,383)

Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission (United States Patent 6,060,065)

Method for preparing an influenza virus, antigens obtained and applications thereof (United States Patent 6,048,537)

Vaccines for equine influenza (United States Patent 6,045,790)

Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B (United States Patent 6,015,664)

Compounds and their combinations for the treatment of influenza infection (United States Patent 6,013,632)

Method and apparatus for detecting cancer, influenza, or HIV based on .alpha.-N-acetyl-galactosaminidase detection (United States Patent 5,998,132)

Influenza vaccine (United States Patent 5,962,298)

Influenza vaccine (United States Patent 5,948,410)

Compounds, compositions and methods for treating influenza (United States Patent 5,935,957)

Liposomal influenza vaccine composition and method (United States Patent 5,919,480)

DNA transcription unit vaccines that protect against avian influenza viruses and methods of use thereof (United States Patent 5,916,879)

Cross-reactive influenza A immunization (United States Patent 5,882,650)

Genetically engineered human immunodeficiency virus-like particles with modified chimeric envelope glycoproteins containing influenza virus transmembrane spanning domains (United States Patent 5,879,925)

Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them (United States Patent 5,879,685)

Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein (United States Patent 5,858,368)

Capped nucleic acid oligomers that inhibit cap-dependent transcription of the influenza virus endonuclease (United States Patent 5,837,852)

Method of treating of preventing influenza (United States Patent 5,824,641)

Influenza virus replicated in mammalian cell culture and vaccine production (United States Patent 5,824,536)

Compounds compositions and methods for treating influenza (United States Patent 5,821,243)

Diagnostic and prognostic ELISA assays of serum .alpha.-N-acetylgalactosaminidase for influenza (United States Patent 5,776,671)

Cross-reactive influenza a immunization (United States Patent 5,766,601)

Method for producing influenza hemagglutinin multivalent vaccines using baculovirus (United States Patent 5,762,939)

Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive (United States Patent 5,741,493)

4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens (United States Patent 5,719,020)

Method for producing influenza virus and vaccine (United States Patent 5,698,433)

Saccharomyces cerevisiae expressing M.sub.2 protein of influenza A virus (United States Patent 5,691,189)

Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene (United States Patent 5,690,937)

DNA coding for variable region to human influenza A type virus (United States Patent 5,684,146)

Pyrazole dimers compositions and methods for treating influenza (United States Patent 5,684,024)

Cross-reactive influenza a immunization (United States Patent 5,674,502)

Methods for diagnosing human influenza and 4-position modified chromogenic N-acetylneuraminic acid substrated for use therein (United States Patent 5,663,055)

DNA polymerase extension assay for influenza virus endonuclease (United States Patent 5,660,989)

Influenza machine (United States Patent 5,639,461)

Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions (United States Patent 5,637,573)

Anti-human influenza virus antibody (United States Patent 5,631,350)

Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease (United States Patent 5,618,830)

M-protein peptides of influenza virus as antiviral agents (United States Patent 5,616,327)

Influenza virus subunit conjugates (United States Patent 5,612,037)

Anti-human influenza virus antibody (United States Patent 5,589,174)

Although his recognition as a registered patent agent permits him to represent others in all patent matters before the United States Patent and Trademark Office, Dr. Demchick limits his practice to patent matters involving inventions for which he is confident that his expertise will allow him to serve his client well. He will gladly discuss whether he is comfortable handling cases involving inventions in a particular field. He will err on the side of declining cases if he has uncertainty about his ability to do what is needed in the case. Dr. Demchick does not represent clients in court. However, he refers clients to a patent attorney who does represent others in court, if it appears likely that patent related representation in court is appropriate. Dr. Demchick prepares and files non-provisional (regular) patent applications and provisional patent applications. He prepares and files utility patent applications and design patent applications. He prepares and files U.S. patent applications and international patent applications under the Patent Cooperation Treaty (PCT). He prepares and files applications to enter the U.S. National Phase for inventions for which international patent applications (PCT) were already filed. One of the matters he discusses with each client or potential client is which type of application(s) best meets that client's needs. He usually does a patent search (patentability search) as part of the preparation of a patent application. He discusses the value of patent searching with each inventor before agreeing to prepare a patent application for that inventor.